Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity.

J Immunother Cancer · 2025 · PMC12506461 · PMID 41052880

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

We hypothesize that this may be attributed to variations in the distribution of IFN-γ + CD4 + T-cell locations, as a significant statistical difference was apparent when employing the IFN-γ + CD4 + T cells to tumor weight ratio in our calculations.

also in 290 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.